{"uri": "eng-9412102", "concepts": [{"uri": "http://en.wikipedia.org/wiki/BioNTech", "type": "wiki", "score": 100, "label": {"eng": "BioNTech"}}, {"uri": "http://en.wikipedia.org/wiki/Oncology", "type": "wiki", "score": 79, "label": {"eng": "Oncology"}}, {"uri": "http://en.wikipedia.org/wiki/Novartis", "type": "org", "score": 73, "label": {"eng": "Novartis"}}, {"uri": "http://en.wikipedia.org/wiki/Biopharmaceutical", "type": "wiki", "score": 41, "label": {"eng": "Biopharmaceutical"}}, {"uri": "http://en.wikipedia.org/wiki/Prostate_cancer", "type": "wiki", "score": 40, "label": {"eng": "Prostate cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Nasdaq", "type": "wiki", "score": 34, "label": {"eng": "Nasdaq"}}, {"uri": "http://en.wikipedia.org/wiki/Mainz", "type": "loc", "score": 34, "label": {"eng": "Mainz"}, "location": {"type": "place", "label": {"eng": "Mainz"}, "country": {"type": "country", "label": {"eng": "Germany"}}}}, {"uri": "http://en.wikipedia.org/wiki/Marketing", "type": "wiki", "score": 31, "label": {"eng": "Marketing"}}, {"uri": "http://en.wikipedia.org/wiki/Healthcare_industry", "type": "wiki", "score": 28, "label": {"eng": "Healthcare industry"}}, {"uri": "http://en.wikipedia.org/wiki/Medication", "type": "wiki", "score": 27, "label": {"eng": "Medication"}}, {"uri": "http://en.wikipedia.org/wiki/Biotechnology", "type": "wiki", "score": 27, "label": {"eng": "Biotechnology"}}, {"uri": "http://en.wikipedia.org/wiki/Chairperson", "type": "wiki", "score": 26, "label": {"eng": "Chairperson"}}, {"uri": "http://en.wikipedia.org/wiki/Neoplasm", "type": "wiki", "score": 26, "label": {"eng": "Neoplasm"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 25, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Lung", "type": "wiki", "score": 23, "label": {"eng": "Lung"}}, {"uri": "http://en.wikipedia.org/wiki/Bristol_Myers_Squibb", "type": "wiki", "score": 21, "label": {"eng": "Bristol Myers Squibb"}}, {"uri": "http://en.wikipedia.org/wiki/Shareholder", "type": "wiki", "score": 15, "label": {"eng": "Shareholder"}}], "eventDate": "2024-03-20", "totalArticleCount": 6, "title": {"eng": "BioNTech names new chief commercial officer ahead of launches By Investing.com"}, "summary": {"eng": "MAINZ, Germany - BioNTech SE (NASDAQ:BNTX), a biopharmaceutical company, announced the appointment of Annemarie Hanekamp as Chief Commercial Officer, effective July 1, 2024. Hanekamp will be succeeding Sean Marett and is transitioning from her role at Novartis AG (SIX:NOVN). She is tasked with driving BioNTech's global commercialization strategy, particularly as the company prepares for its first oncology product launch slated for 2026.\n\nHanekamp brings over two decades of healthcare industry exp"}, "location": {"type": "place", "label": {"eng": "Mainz"}, "country": {"type": "country", "label": {"eng": "Germany"}}}, "categories": [{"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Pharmaceuticals", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Pharmaceuticals", "wgt": 100}, {"uri": "dmoz/Business/Biotechnology_and_Pharmaceuticals/Consulting", "label": "dmoz/Business/Biotechnology and Pharmaceuticals/Consulting", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 82}], "articleCounts": {"eng": 6}, "sentiment": 0.3098039215686275, "wgt": 448588800, "relevance": 1}